首页 > 最新文献

Mycoses最新文献

英文 中文
Pharmacies Counselling of Patients in the Era of Antifungal Resistance. 抗真菌时代的药房对患者的指导。
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-09-01 DOI: 10.1111/myc.13802
Catja Alcoat, Elisabeth M M Christensen, Gregor B E Jemec, Kenneth Skov, Ditte M L Saunte

Background: Tinea pedis is one of the most prevalent superficial fungal infections. Initial antifungal treatment is often acquired over-the-counter (OTC) without previous consultation with a physician.

Objective: Lately, increasing antifungal terbinafine resistance has been documented in Denmark and globally and it is therefore of interest to assess how Danish pharmacies advise customers with tinea pedis.

Methods: One hundred Danish pharmacies were randomly selected and an employee interviewed from each. A structured question guide was followed, with the possibility to add further comments.

Results: Interviews of 94 pharmacies were conducted. Six pharmacies never replied. Terbinafine as standard dose or cutaneous solution terbinafine one time application (Lamisil Once (R)) were recommended by 99% of the pharmacy employees as first-line treatment. The customer was advised to seek medical attention when tinea pedis was recurring (93%), or when treatment duration was > 2 weeks (77%). The majority (88%) of the pharmacy employees had no knowledge about antifungal resistance.

Conclusion: Only few pharmacy employees were aware of the current problem of antifungal resistance and the majority advised costumers to initiate treatment using OTC topical terbinafine. The problem of emerging antifungal resistance requires attention in order to provide customers with tinea pedis effective treatment and prevent further societal spread of resistance to antifungals.

背景:足癣是最常见的浅表真菌感染之一。最初的抗真菌治疗通常是通过非处方药(OTC)获得的,事先并未咨询医生:最近,在丹麦和全球范围内,抗真菌药物特比萘芬的耐药性不断增加,因此,我们有兴趣评估丹麦药店如何为患有足癣的顾客提供建议:随机抽取了 100 家丹麦药店,并对每家药店的一名员工进行了访谈。方法:随机抽取 100 家丹麦药房,每家药房派一名员工接受访谈,访谈采用结构化问题指南,并可添加进一步评论:结果:对 94 家药房进行了访谈。有 6 家药店从未回复。99%的药店员工建议将特比萘芬标准剂量或特比萘芬一次性皮肤溶液(Lamisil Once (R))作为一线治疗药物。当足癣复发(93%)或治疗时间超过两周(77%)时,建议顾客就医。大多数药房员工(88%)对抗真菌耐药性一无所知:结论:只有少数药房员工了解当前的抗真菌耐药性问题,大多数员工建议顾客使用非处方外用特比萘芬开始治疗。新出现的抗真菌药物耐药性问题需要引起重视,以便为患有足癣的顾客提供有效的治疗,并防止抗真菌药物耐药性在社会上进一步蔓延。
{"title":"Pharmacies Counselling of Patients in the Era of Antifungal Resistance.","authors":"Catja Alcoat, Elisabeth M M Christensen, Gregor B E Jemec, Kenneth Skov, Ditte M L Saunte","doi":"10.1111/myc.13802","DOIUrl":"https://doi.org/10.1111/myc.13802","url":null,"abstract":"<p><strong>Background: </strong>Tinea pedis is one of the most prevalent superficial fungal infections. Initial antifungal treatment is often acquired over-the-counter (OTC) without previous consultation with a physician.</p><p><strong>Objective: </strong>Lately, increasing antifungal terbinafine resistance has been documented in Denmark and globally and it is therefore of interest to assess how Danish pharmacies advise customers with tinea pedis.</p><p><strong>Methods: </strong>One hundred Danish pharmacies were randomly selected and an employee interviewed from each. A structured question guide was followed, with the possibility to add further comments.</p><p><strong>Results: </strong>Interviews of 94 pharmacies were conducted. Six pharmacies never replied. Terbinafine as standard dose or cutaneous solution terbinafine one time application (Lamisil Once (R)) were recommended by 99% of the pharmacy employees as first-line treatment. The customer was advised to seek medical attention when tinea pedis was recurring (93%), or when treatment duration was > 2 weeks (77%). The majority (88%) of the pharmacy employees had no knowledge about antifungal resistance.</p><p><strong>Conclusion: </strong>Only few pharmacy employees were aware of the current problem of antifungal resistance and the majority advised costumers to initiate treatment using OTC topical terbinafine. The problem of emerging antifungal resistance requires attention in order to provide customers with tinea pedis effective treatment and prevent further societal spread of resistance to antifungals.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 9","pages":"e13802"},"PeriodicalIF":4.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142350349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High Prevalence of Azole-Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned? 伊朗囊性纤维化患者中耐唑曲霉菌的高流行率:我们应该感到担忧吗?
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-09-01 DOI: 10.1111/myc.13791
Azadeh Bandegani, Mahdi Abastabar, Joobin Sharifisooraki, Zahra Abtahian, Narges Vaseghi, Sadegh Khodavaisy, Atefeh Fakharian, Soheila Khalilzadeh, Mohammad Reza Modaresi, Iman Haghani, Ali Ahmadi, Mona Ghazanfari, Reza Valadan, Hamid Badali

Background: Cystic fibrosis (CF), an inherited autosomal recessive disorder, is linked with high morbidity and mortality rates due to bacteria, filamentous, yeast and black yeast-like fungi colonisation in the upper respiratory tract. Although Candida species are the most common fungi isolated from CF patients, azole-resistant Aspergillus fumigatus (ARAf) is a big concern for invasive aspergillosis. Notably, the exact prevalences of Aspergillus species and the prevalence of ARAf isolates among Iranian CF patients have yet to be previously reported and are unknown. We aimed to investigate the prevalence of ARAf isolates in CF patients among Iranian populations by focusing on molecular mechanisms of the mutations in the target gene.

Methods: The 1 year prospective study recovered 120 sputum samples from 103 CF patients. Of these, 55.1% (86/156) yielded Aspergillus species, screened for ARAf using plates containing itraconazole (4 mg/L) and voriconazole (1 mg/L). According to the CLSI-M38 guidelines, antifungal susceptibility testing was performed using the broth microdilution method. In all phenotypically resistant isolates, the target of azole agents, the cyp51A gene, was sequenced to detect any possible single nucleotide polymorphisms (SNP) mediating resistance.

Results: Of 120 samples, 101 (84.2%) were positive for filamentous fungi and yeast-like relatives, with 156 fungal isolates. The most common colonising fungi were Aspergillus species (55.1%, 86/156), followed by Candida species (39.8%, 62/156), Exophiala species (3.8%, 6/156) and Scedosporium species (1.3%, 2/156). Forty out of 86 (46.5%) were identified for section Fumigati, 36 (41.9%) for section Flavi, 6 (7%) for section Nigri and 4 (4.6%) for section Terrei. Fourteen out of 40 A. fumigatus isolates were phenotypically resistant. The overall proportion of ARAf in total fungal isolates was 9% (14/156). cyp51A gene analysis in resistant isolates revealed that 13 isolates harboured G448S, G432C, T289F, D255E, M220I, M172V, G138C, G54E and F46Y mutations and one isolate carried G448S, G432C, T289F, D255E, M220I, G138C, G54E and F46Y mutations. Additionally, this study detects two novel cyp51A single-nucleotide polymorphisms (I242V and D490E).

Conclusions: This study first investigated ARAf isolates in Iranian CF patients. Due to a resistance rate of up to 9%, it is recommended that susceptibility testing of Aspergillus isolates from CF patients receiving antifungal treatment be a part of the routine diagnostic workup. However, extensive multicentre studies with a high volume of CF patients are highly warranted to determine the impact of ARAf on CF patients.

背景:囊性纤维化(CF)是一种遗传性常染色体隐性疾病,由于细菌、丝状菌、酵母菌和黑酵母样真菌在上呼吸道的定植,CF的发病率和死亡率都很高。虽然念珠菌是 CF 患者最常分离出的真菌,但耐唑曲霉(ARAf)是侵袭性曲霉病的一大隐患。值得注意的是,伊朗 CF 患者中曲霉菌种类的确切流行率和 ARAf 分离物的流行率尚未见报道,目前尚不清楚。我们的目的是通过重点研究目标基因突变的分子机制,调查 ARAf 在伊朗 CF 患者中的流行情况:这项为期一年的前瞻性研究从 103 名 CF 患者中采集了 120 份痰液样本。其中,55.1%(86/156)的样本为曲霉菌,使用含有伊曲康唑(4 毫克/升)和伏立康唑(1 毫克/升)的平板进行 ARAf 筛选。根据 CLSI-M38 指南,抗真菌药敏试验采用肉汤微稀释法进行。对所有表型耐药的分离株进行了唑类药物的靶标--cyp51A基因测序,以检测任何可能介导耐药性的单核苷酸多态性(SNP):结果:在 120 份样本中,101 份(84.2%)对丝状真菌和酵母样近缘菌呈阳性,共分离出 156 种真菌。最常见的定殖真菌是曲霉菌属(55.1%,86/156),其次是念珠菌属(39.8%,62/156)、外孢子菌属(3.8%,6/156)和头孢菌属(1.3%,2/156)。86 个样本中有 40 个(46.5%)被鉴定为 Fumigati 部分,36 个(41.9%)被鉴定为 Flavi 部分,6 个(7%)被鉴定为 Nigri 部分,4 个(4.6%)被鉴定为 Terrei 部分。在 40 个烟曲霉分离物中,有 14 个具有表型抗药性。耐药分离物的 cyp51A 基因分析表明,13 个分离物携带 G448S、G432C、T289F、D255E、M220I、M172V、G138C、G54E 和 F46Y 突变,1 个分离物携带 G448S、G432C、T289F、D255E、M220I、G138C、G54E 和 F46Y 突变。此外,本研究还发现了两种新型 cyp51A 单核苷酸多态性(I242V 和 D490E):本研究首次调查了伊朗 CF 患者的 ARAf 分离物。由于耐药率高达 9%,建议将对接受抗真菌治疗的 CF 患者分离出的曲霉菌进行药敏试验作为常规诊断工作的一部分。不过,要确定 ARAf 对 CF 患者的影响,还需要对大量 CF 患者进行广泛的多中心研究。
{"title":"High Prevalence of Azole-Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned?","authors":"Azadeh Bandegani, Mahdi Abastabar, Joobin Sharifisooraki, Zahra Abtahian, Narges Vaseghi, Sadegh Khodavaisy, Atefeh Fakharian, Soheila Khalilzadeh, Mohammad Reza Modaresi, Iman Haghani, Ali Ahmadi, Mona Ghazanfari, Reza Valadan, Hamid Badali","doi":"10.1111/myc.13791","DOIUrl":"https://doi.org/10.1111/myc.13791","url":null,"abstract":"<p><strong>Background: </strong>Cystic fibrosis (CF), an inherited autosomal recessive disorder, is linked with high morbidity and mortality rates due to bacteria, filamentous, yeast and black yeast-like fungi colonisation in the upper respiratory tract. Although Candida species are the most common fungi isolated from CF patients, azole-resistant Aspergillus fumigatus (ARAf) is a big concern for invasive aspergillosis. Notably, the exact prevalences of Aspergillus species and the prevalence of ARAf isolates among Iranian CF patients have yet to be previously reported and are unknown. We aimed to investigate the prevalence of ARAf isolates in CF patients among Iranian populations by focusing on molecular mechanisms of the mutations in the target gene.</p><p><strong>Methods: </strong>The 1 year prospective study recovered 120 sputum samples from 103 CF patients. Of these, 55.1% (86/156) yielded Aspergillus species, screened for ARAf using plates containing itraconazole (4 mg/L) and voriconazole (1 mg/L). According to the CLSI-M38 guidelines, antifungal susceptibility testing was performed using the broth microdilution method. In all phenotypically resistant isolates, the target of azole agents, the cyp51A gene, was sequenced to detect any possible single nucleotide polymorphisms (SNP) mediating resistance.</p><p><strong>Results: </strong>Of 120 samples, 101 (84.2%) were positive for filamentous fungi and yeast-like relatives, with 156 fungal isolates. The most common colonising fungi were Aspergillus species (55.1%, 86/156), followed by Candida species (39.8%, 62/156), Exophiala species (3.8%, 6/156) and Scedosporium species (1.3%, 2/156). Forty out of 86 (46.5%) were identified for section Fumigati, 36 (41.9%) for section Flavi, 6 (7%) for section Nigri and 4 (4.6%) for section Terrei. Fourteen out of 40 A. fumigatus isolates were phenotypically resistant. The overall proportion of ARAf in total fungal isolates was 9% (14/156). cyp51A gene analysis in resistant isolates revealed that 13 isolates harboured G448S, G432C, T289F, D255E, M220I, M172V, G138C, G54E and F46Y mutations and one isolate carried G448S, G432C, T289F, D255E, M220I, G138C, G54E and F46Y mutations. Additionally, this study detects two novel cyp51A single-nucleotide polymorphisms (I242V and D490E).</p><p><strong>Conclusions: </strong>This study first investigated ARAf isolates in Iranian CF patients. Due to a resistance rate of up to 9%, it is recommended that susceptibility testing of Aspergillus isolates from CF patients receiving antifungal treatment be a part of the routine diagnostic workup. However, extensive multicentre studies with a high volume of CF patients are highly warranted to determine the impact of ARAf on CF patients.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 9","pages":"e13791"},"PeriodicalIF":4.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chromoblastomycosis: A Single Centre Clinical Laboratory Experience of Seven Years (2016-2022) and Literature Review From Pakistan. 着色真菌病:巴基斯坦单中心临床实验室七年(2016-2022 年)经验及文献综述。
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-09-01 DOI: 10.1111/myc.13796
Mohammad Zeeshan, Saira Fatima, Joveria Farooqi, Rabiya Owais, Arsalan Ahmed, Kausar Jabeen, Afia Zafar

Background: Chromoblastomycosis (CBM) is a chronic infection of skin and subcutaneous tissue. CBM cases have been reported in local literature from Pakistan with heterogenous demographic, diagnostic and therapeutic information. The objective of this study is to share the experience of CBM from a large tertiary care hospital laboratory in Pakistan.

Method: This was a retrospective observational study. Histopathology and microbiology data of suspected CBM between 2016 and 2022 was retrieved. Patients' demographics, site of involvement, histopathological findings and positive microbiology cultures were assessed. Literature search on Google Scholar, PubMed and PakMediNet was done between 1990 and 2023 with multiple terms.

Result: A total of 16 CBM cases were identified; 14 were histopathology positive and two were both histopathology and culture positive. The median age was 21 years, and 11 patients were male. The predominant site was lower extremities followed by the face. Severe acanthosis, hyperkeratosis and granuloma with sclerotic bodies were observed in all histopathology slides. Alternaria spp. and Phialophora spp. were isolated from two culture-positive cases. A total of nine cases of CBM were reported from Pakistan in PubMed non-indexed journal.

Conclusion: CBM is not a commonly thought of disease when evaluating skin lesions in Pakistan. A high index of suspicion when assessing patients who may have a history of trauma, exposure to soil and suggestive lesions is reasonable. An integrated approach between clinicians, histopathologist and microbiologist is required to do early identification and therapeutic interventions.

背景:着色真菌病(CBM)是一种皮肤和皮下组织的慢性感染。巴基斯坦当地的文献报道了一些 CBM 病例,这些病例的人口统计学、诊断和治疗信息各不相同。本研究的目的是分享巴基斯坦一家大型三级医院实验室在 CBM 方面的经验:这是一项回顾性观察研究。检索了 2016 年至 2022 年期间疑似 CBM 的组织病理学和微生物学数据。评估了患者的人口统计学特征、受累部位、组织病理学结果和阳性微生物培养。在谷歌学术、PubMed 和 PakMediNet 上进行了 1990 年至 2023 年期间的文献检索,并使用了多个术语:结果:共发现 16 例CBM病例,其中 14 例组织病理学阳性,2 例组织病理学和培养均阳性。中位年龄为 21 岁,11 名患者为男性。主要发病部位是下肢,其次是面部。在所有组织病理切片中均可观察到严重的棘皮症、角化过度症和带有硬化体的肉芽肿。从两例培养阳性病例中分离出了交替孢子菌属和噬菌体属。在 PubMed 非索引期刊中,巴基斯坦共报告了九例 CBM 病例:结论:在巴基斯坦,评估皮肤病变时通常不会想到 CBM。在评估可能有外伤史、土壤接触史和提示性皮损的患者时,高度怀疑是合理的。临床医生、组织病理学家和微生物学家需要采取综合方法来进行早期识别和治疗干预。
{"title":"Chromoblastomycosis: A Single Centre Clinical Laboratory Experience of Seven Years (2016-2022) and Literature Review From Pakistan.","authors":"Mohammad Zeeshan, Saira Fatima, Joveria Farooqi, Rabiya Owais, Arsalan Ahmed, Kausar Jabeen, Afia Zafar","doi":"10.1111/myc.13796","DOIUrl":"https://doi.org/10.1111/myc.13796","url":null,"abstract":"<p><strong>Background: </strong>Chromoblastomycosis (CBM) is a chronic infection of skin and subcutaneous tissue. CBM cases have been reported in local literature from Pakistan with heterogenous demographic, diagnostic and therapeutic information. The objective of this study is to share the experience of CBM from a large tertiary care hospital laboratory in Pakistan.</p><p><strong>Method: </strong>This was a retrospective observational study. Histopathology and microbiology data of suspected CBM between 2016 and 2022 was retrieved. Patients' demographics, site of involvement, histopathological findings and positive microbiology cultures were assessed. Literature search on Google Scholar, PubMed and PakMediNet was done between 1990 and 2023 with multiple terms.</p><p><strong>Result: </strong>A total of 16 CBM cases were identified; 14 were histopathology positive and two were both histopathology and culture positive. The median age was 21 years, and 11 patients were male. The predominant site was lower extremities followed by the face. Severe acanthosis, hyperkeratosis and granuloma with sclerotic bodies were observed in all histopathology slides. Alternaria spp. and Phialophora spp. were isolated from two culture-positive cases. A total of nine cases of CBM were reported from Pakistan in PubMed non-indexed journal.</p><p><strong>Conclusion: </strong>CBM is not a commonly thought of disease when evaluating skin lesions in Pakistan. A high index of suspicion when assessing patients who may have a history of trauma, exposure to soil and suggestive lesions is reasonable. An integrated approach between clinicians, histopathologist and microbiologist is required to do early identification and therapeutic interventions.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 9","pages":"e13796"},"PeriodicalIF":4.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142291504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition). 中国抗真菌皮癣菌管理专家共识(2024 年版)》。
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-09-01 DOI: 10.1111/myc.13785
Guanzhao Liang, Xiaofang Li, Ruoyu Li, Hai Wen, Jun Gu, Yuping Ran, Liyan Xi, Fuqiu Li, Qiangqiang Zhang, Cunwei Cao, Peiying Feng, Meng Fu, Yanping Jiang, Shanshan Li, Hongfang Liu, Zehu Liu, Xuelian Lv, Paride Abliz, Weihua Pan, Hong Sang, Xiaodong She, Dongmei Shi, Zhongsheng Tong, Aiping Wang, Ling Wang, Yuanyuan Xiao, Jie Yang, Lianjuan Yang, Jin Yu, Ping Zhan, Siping Zhang, Yu Zhang, Hongmei Zhu, Min Zhu, Ge Song, Xue Kong, Weida Liu

Antifungal-resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine-resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.

抗真菌耐药皮癣菌(ARD)感染是临床微生物学和皮肤病学领域的热点问题。indotineae 毛癣菌作为皮癣菌中具有特比萘芬耐药性或多药耐药性的优势菌种,临床上容易漏检,给诊断和治疗带来严峻挑战。ARD感染病例已在中国出现,并预示着其在人群中传播的风险。基于现有的医学证据和研究资料,中西医结合皮肤科真菌学组和中国抗真菌⁃耐药皮癣专家共识组组织专家对该感染的处理达成共识。在此,共识制定了诊疗建议,以唤起人们对皮真菌耐药问题的重视,并期望为临床诊断、治疗和防控提供参考信息。
{"title":"Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition).","authors":"Guanzhao Liang, Xiaofang Li, Ruoyu Li, Hai Wen, Jun Gu, Yuping Ran, Liyan Xi, Fuqiu Li, Qiangqiang Zhang, Cunwei Cao, Peiying Feng, Meng Fu, Yanping Jiang, Shanshan Li, Hongfang Liu, Zehu Liu, Xuelian Lv, Paride Abliz, Weihua Pan, Hong Sang, Xiaodong She, Dongmei Shi, Zhongsheng Tong, Aiping Wang, Ling Wang, Yuanyuan Xiao, Jie Yang, Lianjuan Yang, Jin Yu, Ping Zhan, Siping Zhang, Yu Zhang, Hongmei Zhu, Min Zhu, Ge Song, Xue Kong, Weida Liu","doi":"10.1111/myc.13785","DOIUrl":"https://doi.org/10.1111/myc.13785","url":null,"abstract":"<p><p>Antifungal-resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine-resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 9","pages":"e13785"},"PeriodicalIF":4.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Emergence of New Sporothrix brasiliensis Genotypes in Current Epidemic of Sporotrichosis in Southeastern Brazil. 当前巴西东南部孢子丝虫病流行中出现了新的巴西孢子丝虫基因型。
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-09-01 DOI: 10.1111/myc.13792
Salene Angelini Colombo, Jamile Ambrósio de Carvalho, Gustavo Canesso Bicalho, Danielle Ferreira de Magalhães Soares, Camila Stefanie Fonseca de Oliveira, Guilherme Campos Tavares, Anderson Messias Rodrigues, Maria Isabel de Azevedo

Background: Zoonotic sporotrichosis caused by Sporothrix brasiliensis has become the main subcutaneous mycosis in Brazil. Minas Gerais (MG) is located in southeast Brazil and since 2015 has experienced an epidemic of zoonotic sporotrichosis.

Objectives: This study aimed to reconstruct the epidemiological scenario of sporotrichosis from S. brasiliensis in recent epizooty in the Metropolitan Region of Belo Horizonte (MRBH), MG.

Methods: A total of 95 Sporothrix spp. isolates (Sporothirx brasiliensis n = 74, S. schenckii n = 11 and S. globosa n = 10) were subjected to Amplified Fragment Length Polymorphism (AFLP) genotyping and mating-type analysis to determine genetic diversity and population structure. Of these, 46 S. brasiliensis isolates were recovered from animals (cats n = 41 and dogs n = 5) from MRBH.

Results: Our study describes the high interspecific differentiation power of AFLP-based genotyping between the main phylogenetic Sporothrix groups. S. brasiliensis presents high genetic variability and pronounced population structure with geographically focused outbreaks in Brazil. The genetic groups include older genotypes from the prolonged epidemic in Southeast (Rio de Janeiro and São Paulo), South (Rio Grande do Sul), Northeast (Pernambuco) and new genotypes from the MRBH. Furthermore, we provide evidence of heterothallism mating strategy in pathogenic Sporothrix species. Genotypes originating in Rio de Janeiro and Pernambuco carry the predominant MAT1-2 idiomorph as opposed to genotypes from Rio Grande do Sul, which have the MAT1-1 idiomorph. We observed an overwhelming occurrence of MAT1-1 among MRBH isolates.

Conclusion: Our study provides clear evidence of the predominance of a genetic group profile circulating in animals in Minas Gerais, independent of that disseminated from Rio de Janeiro. Our data can help us understand the genetic population processes that drive the evolution of this fungus in Minas Gerais and contribute to future mitigation actions for this ongoing epidemic.

背景:由巴西孢子丝菌(Sporothrix brasiliensis)引起的人畜共患孢子丝菌病已成为巴西主要的皮下真菌病。米纳斯吉拉斯州(MG)位于巴西东南部,自2015年以来经历了一场人畜共患病孢子丝菌病的流行:本研究旨在重建巴西孢子丝菌病在米纳斯吉拉斯州贝洛奥里藏特大都会地区(MRBH)近期疫情中的流行情况:对总共 95 个 Sporothrix 属分离物(Sporothirx brasiliensis n = 74、S. schenckii n = 11 和 S. globosa n = 10)进行了扩增片段长度多态性(AFLP)基因分型和交配型分析,以确定遗传多样性和种群结构。其中,46 个 S. brasiliensis 分离物是从 MRBH 的动物(猫 n = 41 和狗 n = 5)中分离出来的:结果:我们的研究描述了基于 AFLP 的基因分型在 Sporothrix 主要系统发育群之间的高种间分化能力。S. brasiliensis具有很高的遗传变异性和明显的种群结构,在巴西的爆发主要集中在地理位置上。这些基因群包括东南部(里约热内卢和圣保罗)、南部(南里奥格兰德州)、东北部(伯南布哥州)长期流行的老基因型和来自 MRBH 的新基因型。此外,我们还提供了病原Sporothrix种异型交配策略的证据。里约热内卢和伯南布哥的基因型主要携带 MAT1-2 异型体,而南里奥格兰德州的基因型则携带 MAT1-1 异型体。我们观察到,在 MRBH 分离物中,MAT1-1 的出现率极高:我们的研究提供了明确的证据,证明在米纳斯吉拉斯州动物中流行的基因组特征占主导地位,与里约热内卢传播的基因组特征无关。我们的数据有助于我们了解米纳斯吉拉斯州这种真菌进化的遗传种群过程,并有助于未来针对这一持续流行病采取缓解行动。
{"title":"The Emergence of New Sporothrix brasiliensis Genotypes in Current Epidemic of Sporotrichosis in Southeastern Brazil.","authors":"Salene Angelini Colombo, Jamile Ambrósio de Carvalho, Gustavo Canesso Bicalho, Danielle Ferreira de Magalhães Soares, Camila Stefanie Fonseca de Oliveira, Guilherme Campos Tavares, Anderson Messias Rodrigues, Maria Isabel de Azevedo","doi":"10.1111/myc.13792","DOIUrl":"https://doi.org/10.1111/myc.13792","url":null,"abstract":"<p><strong>Background: </strong>Zoonotic sporotrichosis caused by Sporothrix brasiliensis has become the main subcutaneous mycosis in Brazil. Minas Gerais (MG) is located in southeast Brazil and since 2015 has experienced an epidemic of zoonotic sporotrichosis.</p><p><strong>Objectives: </strong>This study aimed to reconstruct the epidemiological scenario of sporotrichosis from S. brasiliensis in recent epizooty in the Metropolitan Region of Belo Horizonte (MRBH), MG.</p><p><strong>Methods: </strong>A total of 95 Sporothrix spp. isolates (Sporothirx brasiliensis n = 74, S. schenckii n = 11 and S. globosa n = 10) were subjected to Amplified Fragment Length Polymorphism (AFLP) genotyping and mating-type analysis to determine genetic diversity and population structure. Of these, 46 S. brasiliensis isolates were recovered from animals (cats n = 41 and dogs n = 5) from MRBH.</p><p><strong>Results: </strong>Our study describes the high interspecific differentiation power of AFLP-based genotyping between the main phylogenetic Sporothrix groups. S. brasiliensis presents high genetic variability and pronounced population structure with geographically focused outbreaks in Brazil. The genetic groups include older genotypes from the prolonged epidemic in Southeast (Rio de Janeiro and São Paulo), South (Rio Grande do Sul), Northeast (Pernambuco) and new genotypes from the MRBH. Furthermore, we provide evidence of heterothallism mating strategy in pathogenic Sporothrix species. Genotypes originating in Rio de Janeiro and Pernambuco carry the predominant MAT1-2 idiomorph as opposed to genotypes from Rio Grande do Sul, which have the MAT1-1 idiomorph. We observed an overwhelming occurrence of MAT1-1 among MRBH isolates.</p><p><strong>Conclusion: </strong>Our study provides clear evidence of the predominance of a genetic group profile circulating in animals in Minas Gerais, independent of that disseminated from Rio de Janeiro. Our data can help us understand the genetic population processes that drive the evolution of this fungus in Minas Gerais and contribute to future mitigation actions for this ongoing epidemic.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 9","pages":"e13792"},"PeriodicalIF":4.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis. 不同临床表现的人类孢子丝虫病患者的抗体同型和亚类反应
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-09-01 DOI: 10.1111/myc.13793
Rodrigo Almeida-Paes, Camila Jantoro Guzman Lugones, Marcos Abreu Almeida, Marcel de Souza Borges Quintana, Maurício Sá Benevides-Freitas, Joyce Rodrigues Ribeiro, Dayvison Francis Saraiva Freitas, Priscila Marques de Macedo, Antonio Carlos Francesconi do Valle, Rosely Maria Zancopé-Oliveira, Maria Clara Gutierrez-Galhardo

Sporotrichosis diagnosis involves a series of analyses, including culture and antibody detection in serum samples. Serologic methods may sometimes yield false-negative or false-positive results, leading to inaccurate diagnoses. This study assessed specific patient groups in which antibody detection of different isotypes and subclasses may lack sensitivity. An enzyme-linked immunosorbent assay (ELISA) with Sporothrix brasiliensis exoantigens was used to investigate IgM, IgG, IgG1, IgG2, IgG3, IgG4, IgA, IgA1 and IgA2 antibodies in human serum samples. Eighty serum samples from patients with different sporotrichosis clinical manifestations, including cutaneous forms with and without hypersensitivity manifestations, extracutaneous forms (bone, ocular, meningeal and pulmonary), disseminated cutaneous forms and disseminated forms in individuals living with HIV/AIDS, diabetics and alcoholics, were evaluated. The ELISA sensitivities in the detection of different antibodies ranged from 0.85 to 0.60 for the detection of IgG2 and IgG3, respectively. The antibodies with higher area under ROC curves were IgG2, IgG, IgA and IgA1. There were no significant differences in the immunological reactivity of the tested antibodies among different clinical forms of sporotrichosis. The data revealed a higher likelihood of a false-negative outcome in patients with lesions in the nasal mucosa regarding the detection of IgM and a lower likelihood in patients with lymphocutaneous sporotrichosis regarding the detection of IgG3. Patients with hypersensitivity manifestations had a 3.71 odds ratio to yield negative results in total IgG detection. In conclusion, we identified specific patient groups in which antibody detection may lack sensitivity, thus contributing to a better understanding of the diagnostic challenges associated with this condition.

孢子丝菌病的诊断需要进行一系列分析,包括培养和血清样本中的抗体检测。血清学方法有时会产生假阴性或假阳性结果,导致诊断不准确。本研究评估了特定的患者群体,在这些群体中,不同同型和亚型的抗体检测可能缺乏敏感性。研究人员使用一种带有巴西黑孢子虫外抗原的酶联免疫吸附试验(ELISA)来检测人体血清样本中的 IgM、IgG、IgG1、IgG2、IgG3、IgG4、IgA、IgA1 和 IgA2 抗体。对 80 份来自不同孢子丝菌病临床表现患者的血清样本进行了评估,这些临床表现包括有或无超敏表现的皮肤型、皮肤外型(骨、眼、脑膜和肺部)、播散性皮肤型以及艾滋病毒/艾滋病患者、糖尿病患者和酗酒者的播散型。ELISA 检测不同抗体的灵敏度从 0.85 到 0.60 不等,分别检测 IgG2 和 IgG3。ROC曲线下面积较大的抗体是IgG2、IgG、IgA和IgA1。在不同临床形式的孢子丝虫病中,检测抗体的免疫反应性没有明显差异。数据显示,检测 IgM 时,鼻粘膜病变患者出现假阴性结果的可能性较高,而检测 IgG3 时,淋巴皮肤孢子丝菌病患者出现假阴性结果的可能性较低。有超敏表现的患者总 IgG 检测结果为阴性的几率为 3.71。总之,我们确定了抗体检测可能缺乏敏感性的特定患者群体,从而有助于更好地理解与这种疾病相关的诊断难题。
{"title":"Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis.","authors":"Rodrigo Almeida-Paes, Camila Jantoro Guzman Lugones, Marcos Abreu Almeida, Marcel de Souza Borges Quintana, Maurício Sá Benevides-Freitas, Joyce Rodrigues Ribeiro, Dayvison Francis Saraiva Freitas, Priscila Marques de Macedo, Antonio Carlos Francesconi do Valle, Rosely Maria Zancopé-Oliveira, Maria Clara Gutierrez-Galhardo","doi":"10.1111/myc.13793","DOIUrl":"https://doi.org/10.1111/myc.13793","url":null,"abstract":"<p><p>Sporotrichosis diagnosis involves a series of analyses, including culture and antibody detection in serum samples. Serologic methods may sometimes yield false-negative or false-positive results, leading to inaccurate diagnoses. This study assessed specific patient groups in which antibody detection of different isotypes and subclasses may lack sensitivity. An enzyme-linked immunosorbent assay (ELISA) with Sporothrix brasiliensis exoantigens was used to investigate IgM, IgG, IgG1, IgG2, IgG3, IgG4, IgA, IgA1 and IgA2 antibodies in human serum samples. Eighty serum samples from patients with different sporotrichosis clinical manifestations, including cutaneous forms with and without hypersensitivity manifestations, extracutaneous forms (bone, ocular, meningeal and pulmonary), disseminated cutaneous forms and disseminated forms in individuals living with HIV/AIDS, diabetics and alcoholics, were evaluated. The ELISA sensitivities in the detection of different antibodies ranged from 0.85 to 0.60 for the detection of IgG2 and IgG3, respectively. The antibodies with higher area under ROC curves were IgG2, IgG, IgA and IgA1. There were no significant differences in the immunological reactivity of the tested antibodies among different clinical forms of sporotrichosis. The data revealed a higher likelihood of a false-negative outcome in patients with lesions in the nasal mucosa regarding the detection of IgM and a lower likelihood in patients with lymphocutaneous sporotrichosis regarding the detection of IgG3. Patients with hypersensitivity manifestations had a 3.71 odds ratio to yield negative results in total IgG detection. In conclusion, we identified specific patient groups in which antibody detection may lack sensitivity, thus contributing to a better understanding of the diagnostic challenges associated with this condition.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 9","pages":"e13793"},"PeriodicalIF":4.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142140476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Candidaemia and Central Line-Associated Candidaemia in a Network of Indian ICUs: Impact of COVID-19 Pandemic. 印度重症监护室网络中的念珠菌血症和中央管路相关念珠菌血症:COVID-19 大流行的影响。
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-09-01 DOI: 10.1111/myc.13790
Purva Mathur, Sharad Srivastav, Arpan Kumar Thakur, Rasna Parveen, Mamta Puraswani, Ashish Kumar Srivastava, Arunaloke Chakrabarti, Camilla Rodrigues, Veeraraghavan Balaji, Pallab Ray, Manisha Biswal, Chand Wattal, Vimala Venkatesh, Nandini Sethuraman, Sanjay Bhattacharya, Vijaya Lakshmi Nag, Vibhor Tak, Bijayini Behera, Neeraj Goel, Jyoti Iravane, Sudipta Mukherjee, Raja Ray, Sanjeev K Singh, Chiranjay Mukhopadhyay, Joy Sarojini Michael, Bashir Ahmad Fomda, Juliah Chelliah, Anjali Shetty, Tadepalli Karuna, Aparna Ningombam, Subodh Kumar, Kapil Dev Soni, Sushma Sagar, Richa Aggrawal, Deepak Gupta, Gyaninder Pal Singh, Ashish Bindra, Kamran Farooque, Shashank Purwar, Sagar Khadanga, K E Vandana, Muralidhar Varma, Vijayshri Deotale, Padma Das, Ruchita Lohiya, Amber Prasad, Puneet Kumar Gupta, Balram Ji Omar, Ankit Aggarwal, Sherish Baqal, Khuraijam Ranjana Devi, L Chaoba Singh, Soumyadip Chatterji, Gaurav Goel, Satyam Mukherjee, Yamunadevi V Ramanathan, Aparna Sonowal, Prachi Verma, Ashoka Mahapatra, Vinaykumar Hallur, Ujjwala Nitin Gaikwad, Anudita Bhargava, Kanne Padmaja, Nagari Bheerappa, Vidhi Jain, Pradeep Bhatia, Kuldeep Singh, Daisy Khera, Neeraj Gupta, Hema Paul, Sheetal Verma, Zia Arshad, Ratinder Jhaj, Shikha Malik, M A Thirunarayan, Hirak Jyoti Raj, Prashant Gupta, Dandu Himanshu, Shivaprakash M Rudramurthy, Reema Nath, Renu Gur, Nari M Lyngdoh, Clarissa Lyngdoh, Sheela Devi, Shalini Malhotra, Rajni Gaind, Rushika Saksena, Rajni Sharma, Kamini Walia

Background and objectives: Candidaemia is a potentially life-threatening emergency in the intensive care units (ICUs). Surveillance using common protocols in a large network of hospitals would give meaningful estimates of the burden of candidaemia and central line associated candidaemia in low resource settings. We undertook this study to understand the burden and epidemiology of candidaemia in multiple ICUs of India, leveraging the previously established healthcare-associated infections (HAI) surveillance network. Our aim was also to assess the impact that the pandemic of COVID-19 had on the rates and associated mortality of candidaemia.

Methods: This study included adult patients from 67 Indian ICUs in the AIIMS-HAI surveillance network that conducted BSI surveillance in COVID-19 and non-COVID-19 ICUs during and before the COVID-19 pandemic periods. Hospitals identified healthcare-associated candidaemia and central line associated candidaemia and reported clinical and microbiological data to the network as per established and previously published protocols.

Results: A total of 401,601 patient days and 126,051 central line days were reported during the study period. A total of 377 events of candidaemia were recorded. The overall rate of candidaemia in our network was 0.93/1000 patient days. The rate of candidaemia in COVID-19 ICUs (2.52/1000 patient days) was significantly higher than in non-COVID-19 ICUs (1.05/patient days) during the pandemic period. The rate of central line associated candidaemia in COVID-19 ICUs (4.53/1000 central line days) was also significantly higher than in non-COVID-19 ICUs (1.73/1000 central line days) during the pandemic period. Mortality in COVID-19 ICUs associated with candidaemia (61%) was higher than that in non-COVID-19 ICUs (41%). A total of 435 Candida spp. were isolated. C. tropicalis (26.7%) was the most common species. C. auris accounted for 17.5% of all isolates and had a high mortality.

Conclusion: Patients in ICUs with COVID-19 infections have a much higher risk of candidaemia, CLAC and its associated mortality. Network level data helps in understanding the true burden of candidaemia and will help in framing infection control policies for the country.

背景和目的:念珠菌血症是重症监护病房(ICU)中可能危及生命的急症。在大型医院网络中使用通用协议进行监测,可对低资源环境中念珠菌血症和中央管路相关念珠菌血症的负担做出有意义的估计。我们利用以前建立的医疗相关感染(HAI)监测网络开展了这项研究,以了解印度多个重症监护病房的念珠菌血症负担和流行病学。我们的目的还在于评估 COVID-19 大流行对念珠菌血症发病率和相关死亡率的影响:本研究纳入了 AIIMS-HAI 监控网络中 67 个印度 ICU 的成年患者,这些 ICU 在 COVID-19 大流行期间和之前对 COVID-19 和非 COVID-19 ICU 进行了 BSI 监控。各医院按照先前公布的既定规程确定了医源性念珠菌血症和中央管路相关念珠菌血症,并向网络报告了临床和微生物学数据:研究期间共报告了 401,601 个患者日和 126,051 个中心管路日。共记录了 377 例念珠菌血症。在我们的网络中,念珠菌血症的总发生率为 0.93/1000 个患者日。在大流行期间,COVID-19 重症监护病房的念珠菌血症发生率(2.52/1000 患者日)明显高于非 COVID-19 重症监护病房(1.05/患者日)。在大流行期间,COVID-19 重症监护病房的中心管路相关念珠菌血症发生率(4.53/1000 中心管路日)也明显高于非 COVID-19 重症监护病房(1.73/1000 中心管路日)。与念珠菌血症相关的 COVID-19 ICU 死亡率(61%)高于非 COVID-19 ICU 死亡率(41%)。共分离出 435 个念珠菌属。热带念珠菌(26.7%)是最常见的菌种。在所有分离菌中,白色念珠菌占17.5%,死亡率较高:结论:感染 COVID-19 的重症监护病房患者发生念珠菌血症、CLAC 及其相关死亡率的风险要高得多。网络层面的数据有助于了解念珠菌血症的真正负担,并有助于制定国家感染控制政策。
{"title":"Candidaemia and Central Line-Associated Candidaemia in a Network of Indian ICUs: Impact of COVID-19 Pandemic.","authors":"Purva Mathur, Sharad Srivastav, Arpan Kumar Thakur, Rasna Parveen, Mamta Puraswani, Ashish Kumar Srivastava, Arunaloke Chakrabarti, Camilla Rodrigues, Veeraraghavan Balaji, Pallab Ray, Manisha Biswal, Chand Wattal, Vimala Venkatesh, Nandini Sethuraman, Sanjay Bhattacharya, Vijaya Lakshmi Nag, Vibhor Tak, Bijayini Behera, Neeraj Goel, Jyoti Iravane, Sudipta Mukherjee, Raja Ray, Sanjeev K Singh, Chiranjay Mukhopadhyay, Joy Sarojini Michael, Bashir Ahmad Fomda, Juliah Chelliah, Anjali Shetty, Tadepalli Karuna, Aparna Ningombam, Subodh Kumar, Kapil Dev Soni, Sushma Sagar, Richa Aggrawal, Deepak Gupta, Gyaninder Pal Singh, Ashish Bindra, Kamran Farooque, Shashank Purwar, Sagar Khadanga, K E Vandana, Muralidhar Varma, Vijayshri Deotale, Padma Das, Ruchita Lohiya, Amber Prasad, Puneet Kumar Gupta, Balram Ji Omar, Ankit Aggarwal, Sherish Baqal, Khuraijam Ranjana Devi, L Chaoba Singh, Soumyadip Chatterji, Gaurav Goel, Satyam Mukherjee, Yamunadevi V Ramanathan, Aparna Sonowal, Prachi Verma, Ashoka Mahapatra, Vinaykumar Hallur, Ujjwala Nitin Gaikwad, Anudita Bhargava, Kanne Padmaja, Nagari Bheerappa, Vidhi Jain, Pradeep Bhatia, Kuldeep Singh, Daisy Khera, Neeraj Gupta, Hema Paul, Sheetal Verma, Zia Arshad, Ratinder Jhaj, Shikha Malik, M A Thirunarayan, Hirak Jyoti Raj, Prashant Gupta, Dandu Himanshu, Shivaprakash M Rudramurthy, Reema Nath, Renu Gur, Nari M Lyngdoh, Clarissa Lyngdoh, Sheela Devi, Shalini Malhotra, Rajni Gaind, Rushika Saksena, Rajni Sharma, Kamini Walia","doi":"10.1111/myc.13790","DOIUrl":"https://doi.org/10.1111/myc.13790","url":null,"abstract":"<p><strong>Background and objectives: </strong>Candidaemia is a potentially life-threatening emergency in the intensive care units (ICUs). Surveillance using common protocols in a large network of hospitals would give meaningful estimates of the burden of candidaemia and central line associated candidaemia in low resource settings. We undertook this study to understand the burden and epidemiology of candidaemia in multiple ICUs of India, leveraging the previously established healthcare-associated infections (HAI) surveillance network. Our aim was also to assess the impact that the pandemic of COVID-19 had on the rates and associated mortality of candidaemia.</p><p><strong>Methods: </strong>This study included adult patients from 67 Indian ICUs in the AIIMS-HAI surveillance network that conducted BSI surveillance in COVID-19 and non-COVID-19 ICUs during and before the COVID-19 pandemic periods. Hospitals identified healthcare-associated candidaemia and central line associated candidaemia and reported clinical and microbiological data to the network as per established and previously published protocols.</p><p><strong>Results: </strong>A total of 401,601 patient days and 126,051 central line days were reported during the study period. A total of 377 events of candidaemia were recorded. The overall rate of candidaemia in our network was 0.93/1000 patient days. The rate of candidaemia in COVID-19 ICUs (2.52/1000 patient days) was significantly higher than in non-COVID-19 ICUs (1.05/patient days) during the pandemic period. The rate of central line associated candidaemia in COVID-19 ICUs (4.53/1000 central line days) was also significantly higher than in non-COVID-19 ICUs (1.73/1000 central line days) during the pandemic period. Mortality in COVID-19 ICUs associated with candidaemia (61%) was higher than that in non-COVID-19 ICUs (41%). A total of 435 Candida spp. were isolated. C. tropicalis (26.7%) was the most common species. C. auris accounted for 17.5% of all isolates and had a high mortality.</p><p><strong>Conclusion: </strong>Patients in ICUs with COVID-19 infections have a much higher risk of candidaemia, CLAC and its associated mortality. Network level data helps in understanding the true burden of candidaemia and will help in framing infection control policies for the country.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 9","pages":"e13790"},"PeriodicalIF":4.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142291503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene. 用特比萘芬或伊曲康唑长期治疗由吲哚毛癣菌引起的皮肤癣菌病,无论角鲨烯环氧化酶基因是否发生变异,都能取得更好的疗效。
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1111/myc.13778
Dipika Shaw, Sunil Dogra, Shreya Singh, Shikha Shah, Tarun Narang, Harsimran Kaur, Kamini Walia, Anup Ghosh, Sanjeev Handa, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy
<p><strong>Background: </strong>Over the past decades, the increasing incidence of recurrent dermatophytosis associated with terbinafine-resistant Trichophyton has posed a serious challenge in management of dermatophytosis. Independent reports of failure of treatment and high minimum inhibitory concentrations (MIC) of antifungals are available, but data correlating MIC and clinical outcomes is still sparse. Therefore, the present study was conducted to evaluate the outcomes of systemic treatment of dermatophytosis and its correlation with MIC of the etiological agents isolated from such patients.</p><p><strong>Methods: </strong>Retrospective analysis of 587 consecutive patients with dermatophytosis was done from March 2017 to March 2019. Demographic and clinical details of the patients were noted, along with the results of direct microscopy and fungal culture. The isolates were identified by sequencing the internal transcribed spacer region of rDNA. Antifungal susceptibility testing was performed following the CLSI M38 protocol. Mutation in the squalene epoxidase (SE) gene was detected by DNA sequencing and ARMS-PCR. Based on the culture-positivity and prescribed systemic antifungal, patients were categorised into Group I culture-positive cases treated with systemic terbinafine and Group II culture-positive cases treated with systemic itraconazole, each for a total period of 12 weeks.</p><p><strong>Results: </strong>In the present study, 477 (81.39%) were culture-positive; however, 12 weeks follow-up was available for 294 patients (Group I-157 and Group II-137) who were included for statistical analysis. In both groups [Group I-37/63 (51.4%) and Group II-14/54 (58.3%)], a better cure rate was observed if the initiation of therapy was performed within <6 months of illness. Treatment outcome revealed that if therapy was extended for 8-12 weeks, the odds of cure rate are significantly better (p < .001) with either itraconazole (Odd Ratio-15.5) or terbinafine (Odd Ratio-4.34). Higher MICs for terbinafine were noted in 41 cases (cured-18 and uncured-23) in Group I and 39 cases (cured-16 and uncured-23) in Group II. From cured (Group I-17/18; 94.4% and Group II-14/16; 87.5%) and uncured (Group I-20/23; 86.9% and Group II-21/23; 91.3%) cases had F397L mutation in the SE gene. No significant difference in cure rate was observed in patients with Trichophyton spp. having terbinafine MIC ≥ 1or <1 μg/mL (Group I-p = .712 and Group II-p = .69).</p><p><strong>Conclusion: </strong>This study revealed that prolonging terbinafine or itraconazole therapy for beyond 8 weeks rather than the standard 4 weeks significantly increases the cure rate. Moreover, no correlation has been observed between antifungal susceptibility and clinical outcomes. The MIC remains the primary parameter for defining antifungal activity and predicting the potency of antifungal agents against specific fungi. However, predicting therapeutic success based solely on the MIC of a fungal strain
背景:过去几十年来,耐特比萘芬毛癣菌引起的复发性皮肤癣菌病发病率不断上升,给皮肤癣菌病的治疗带来了严峻挑战。目前已有关于治疗失败和抗真菌药物最低抑菌浓度(MIC)过高的独立报告,但将 MIC 与临床结果相关联的数据仍然很少。因此,本研究旨在评估皮肤癣菌病的系统治疗效果及其与从此类患者体内分离出的病原菌 MIC 的相关性:2017年3月至2019年3月,对587名连续的皮癣患者进行了回顾性分析。记录了患者的人口统计学和临床详情,以及直接显微镜检查和真菌培养的结果。通过 rDNA 内部转录间隔区测序对分离菌进行鉴定。抗真菌药敏试验按照 CLSI M38 协议进行。通过 DNA 测序和 ARMS-PCR 检测角鲨烯环氧化物酶(SE)基因突变。根据培养阳性和处方的全身抗真菌药物,将患者分为培养阳性 I 组和 II 组,前者使用特比萘芬进行全身治疗,后者使用伊曲康唑进行全身治疗,疗程均为 12 周:在本研究中,有 477 例(81.39%)患者的培养呈阳性,但有 294 例患者(I 组-157 例,II 组-137 例)的 12 周随访资料可用于统计分析。在两组患者中[第一组-37/63(51.4%),第二组-14/54(58.3%)],如果在12周内开始治疗,治愈率更高:本研究表明,将特比萘芬或伊曲康唑的治疗时间延长至 8 周以上而不是标准的 4 周,可显著提高治愈率。此外,抗真菌药物敏感性与临床结果之间没有相关性。MIC 仍是确定抗真菌活性和预测抗真菌药物对特定真菌效力的主要参数。然而,仅仅根据真菌菌株的 MIC 值来预测治疗成功与否并不总是可靠的,因为研究表明体外数据与体内结果之间的相关性很差。为解决这一问题,需要进一步将抗真菌药敏试验(AFST)数据与临床结果和治疗药物监测联系起来。该研究还强调,应在以下时间内开始治疗
{"title":"Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene.","authors":"Dipika Shaw, Sunil Dogra, Shreya Singh, Shikha Shah, Tarun Narang, Harsimran Kaur, Kamini Walia, Anup Ghosh, Sanjeev Handa, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy","doi":"10.1111/myc.13778","DOIUrl":"10.1111/myc.13778","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Over the past decades, the increasing incidence of recurrent dermatophytosis associated with terbinafine-resistant Trichophyton has posed a serious challenge in management of dermatophytosis. Independent reports of failure of treatment and high minimum inhibitory concentrations (MIC) of antifungals are available, but data correlating MIC and clinical outcomes is still sparse. Therefore, the present study was conducted to evaluate the outcomes of systemic treatment of dermatophytosis and its correlation with MIC of the etiological agents isolated from such patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Retrospective analysis of 587 consecutive patients with dermatophytosis was done from March 2017 to March 2019. Demographic and clinical details of the patients were noted, along with the results of direct microscopy and fungal culture. The isolates were identified by sequencing the internal transcribed spacer region of rDNA. Antifungal susceptibility testing was performed following the CLSI M38 protocol. Mutation in the squalene epoxidase (SE) gene was detected by DNA sequencing and ARMS-PCR. Based on the culture-positivity and prescribed systemic antifungal, patients were categorised into Group I culture-positive cases treated with systemic terbinafine and Group II culture-positive cases treated with systemic itraconazole, each for a total period of 12 weeks.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In the present study, 477 (81.39%) were culture-positive; however, 12 weeks follow-up was available for 294 patients (Group I-157 and Group II-137) who were included for statistical analysis. In both groups [Group I-37/63 (51.4%) and Group II-14/54 (58.3%)], a better cure rate was observed if the initiation of therapy was performed within &lt;6 months of illness. Treatment outcome revealed that if therapy was extended for 8-12 weeks, the odds of cure rate are significantly better (p &lt; .001) with either itraconazole (Odd Ratio-15.5) or terbinafine (Odd Ratio-4.34). Higher MICs for terbinafine were noted in 41 cases (cured-18 and uncured-23) in Group I and 39 cases (cured-16 and uncured-23) in Group II. From cured (Group I-17/18; 94.4% and Group II-14/16; 87.5%) and uncured (Group I-20/23; 86.9% and Group II-21/23; 91.3%) cases had F397L mutation in the SE gene. No significant difference in cure rate was observed in patients with Trichophyton spp. having terbinafine MIC ≥ 1or &lt;1 μg/mL (Group I-p = .712 and Group II-p = .69).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This study revealed that prolonging terbinafine or itraconazole therapy for beyond 8 weeks rather than the standard 4 weeks significantly increases the cure rate. Moreover, no correlation has been observed between antifungal susceptibility and clinical outcomes. The MIC remains the primary parameter for defining antifungal activity and predicting the potency of antifungal agents against specific fungi. However, predicting therapeutic success based solely on the MIC of a fungal strain ","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 8","pages":"e13778"},"PeriodicalIF":4.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141860324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inopinatus corneliae sp. nov. gen. nov. isolated from human skin: A newly discovered keratinophilic hyphomycete, order Onygenales. Inopinatus corneliae sp:A newly discovered keratinophilic hyphomycete, order Onygenales.
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1111/myc.13774
Jochen Brasch, Yvonne Gräser, Karen Voss, Katharina Antonia Langen, Andrey Yurkov

Background: Fungi clinically relevant to human skin comprise prevalent commensals and well-known pathogens. Only rarely human skin harbours fungi that evade identification.

Objective: To characterise an enigmatic specimen isolated from a skin lesion.

Methods: A comprehensive clinical and mycological workup including conventional methods for phenotypic characterisation and sequencing based on internal transcribed spacer (ITS) and large subunit (LSU) regions to infer a phylogenetic tree.

Results: Cultures on common solid media were macroscopically inconspicuous initially until mycelial tufts developed on the surface, notably on potato dextrose agar. Polymorphous chlamydospores were detected but no aleurospores and ascomata. At 26°C, the isolate grew on standard agars, plant materials and garden soil and utilised peptone, keratins, lipids, inulin, erythrocytes and cellulose. It also grew at 5°C and at 37°C. Nucleotide sequences of its ITS region showed 93% similarity to sequences of different Malbranchea species. The closest matches among LSU rRNA sequences were obtained with the genera Amauroascus, Arthroderma, Auxarthronopsis and Malbranchea (93%-95%). A combined phylogenetic analysis placed the fungus in a sister clade to Neogymnomycetaceae, classified as incertae sedis in Onygenales, on a large distance to either Diploospora rosea or 'Amauroascus' aureus.

Conclusions: The genus Inopinatus gen. nov. (MB854685) with the species Inopinatus corneliae sp. nov. (MB854687) is introduced to accommodate our isolate (holotype: DSM 116806; isotypes: CBS 151104, IHEM 29063). Probably Inopinatus corneliae is a geophilic species that, although potentially harmful, was no relevant pathogen in our case. Its ecology, epidemiology and pathogenicity need to be further clarified.

背景:临床上与人体皮肤相关的真菌包括常见的共生真菌和众所周知的病原体。只有在极少数情况下,人体皮肤上才会藏有一些无法识别的真菌:目的:描述从皮肤病变中分离出的神秘标本的特征:方法:对标本进行全面的临床和真菌学检查,包括传统的表型鉴定方法和基于内部转录间隔区(ITS)和大亚基(LSU)区域的测序,以推断系统发生树:在普通固体培养基上的培养物最初宏观上并不明显,直到表面长出菌丝丛,尤其是在马铃薯葡萄糖琼脂上。能检测到多形衣壳孢子,但没有黑孢和伞形孢子。在 26°C 时,该分离菌在标准琼脂、植物材料和花园土壤上生长,并利用蛋白胨、角蛋白、脂质、菊粉、红细胞和纤维素。它还能在 5°C 和 37°C 温度下生长。其 ITS 区域的核苷酸序列与不同 Malbranchea 物种的序列有 93% 的相似性。LSU rRNA序列与Amauroascus属、Arthroderma属、Auxarthronopsis属和Malbranchea属的匹配度最高(93%-95%)。综合系统进化分析将该真菌归入新裸子植物(Neogymnomycetaceae)的姊妹支系,被归类为Onygenales中的incertae sedis,与Diploospora rosea或'Amauroascus' aureus有很大的距离:Nov.属(MB854685)和新种 Inopinatus corneliae sp.(MB854687),以适应我们的分离物(主模式:DSM 116806;等模式:CBS 151104,IHEM 29063)。可能 Inopinatus corneliae 是一种嗜地性物种,虽然可能有害,但在我们的病例中并不是相关的病原体。其生态学、流行病学和致病性有待进一步澄清。
{"title":"Inopinatus corneliae sp. nov. gen. nov. isolated from human skin: A newly discovered keratinophilic hyphomycete, order Onygenales.","authors":"Jochen Brasch, Yvonne Gräser, Karen Voss, Katharina Antonia Langen, Andrey Yurkov","doi":"10.1111/myc.13774","DOIUrl":"https://doi.org/10.1111/myc.13774","url":null,"abstract":"<p><strong>Background: </strong>Fungi clinically relevant to human skin comprise prevalent commensals and well-known pathogens. Only rarely human skin harbours fungi that evade identification.</p><p><strong>Objective: </strong>To characterise an enigmatic specimen isolated from a skin lesion.</p><p><strong>Methods: </strong>A comprehensive clinical and mycological workup including conventional methods for phenotypic characterisation and sequencing based on internal transcribed spacer (ITS) and large subunit (LSU) regions to infer a phylogenetic tree.</p><p><strong>Results: </strong>Cultures on common solid media were macroscopically inconspicuous initially until mycelial tufts developed on the surface, notably on potato dextrose agar. Polymorphous chlamydospores were detected but no aleurospores and ascomata. At 26°C, the isolate grew on standard agars, plant materials and garden soil and utilised peptone, keratins, lipids, inulin, erythrocytes and cellulose. It also grew at 5°C and at 37°C. Nucleotide sequences of its ITS region showed 93% similarity to sequences of different Malbranchea species. The closest matches among LSU rRNA sequences were obtained with the genera Amauroascus, Arthroderma, Auxarthronopsis and Malbranchea (93%-95%). A combined phylogenetic analysis placed the fungus in a sister clade to Neogymnomycetaceae, classified as incertae sedis in Onygenales, on a large distance to either Diploospora rosea or 'Amauroascus' aureus.</p><p><strong>Conclusions: </strong>The genus Inopinatus gen. nov. (MB854685) with the species Inopinatus corneliae sp. nov. (MB854687) is introduced to accommodate our isolate (holotype: DSM 116806; isotypes: CBS 151104, IHEM 29063). Probably Inopinatus corneliae is a geophilic species that, although potentially harmful, was no relevant pathogen in our case. Its ecology, epidemiology and pathogenicity need to be further clarified.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 8","pages":"e13774"},"PeriodicalIF":4.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revision of antifungal strategies definitions for invasive fungal infections (proven/probable/possible) in 461 patients with haematological malignancies (REDEFI-SEIFEM). 修订 461 例血液学恶性肿瘤患者侵袭性真菌感染(已证实/可能/可能)的抗真菌策略定义(REDEFI-SEIFEM)。
IF 4.1 2区 医学 Q1 DERMATOLOGY Pub Date : 2024-08-01 DOI: 10.1111/myc.13781
Criscuolo Marianna, Bonanni Matteo, Piciocchi Alfonso, Farina Francesca, Verga Luisa, Marchesi Francesco, Basilico Claudia, Del Principe Maria Ilaria, Tisi Maria Chiara, Cattaneo Chiara, Picardi Marco, Bonuomo Valentina, Fracchiolla Nicola, Candoni Anna, Perruccio Katia, Stanzani Marta, Larici Anna Rita, Sanguinetti Maurizio, Busca Alessandro, Pagano Livio

Background: Invasive fungal infections (IFI) are a relevant cause of morbidity and mortality among patients with haematological neoplasms (HMs). Since 2002, a classification of IFI based on host factors, clinical and radiological features and mycological tests was published for research purpose.

Objectives: These criteria are widely used in clinical practice to identify patients at risk for IFI. The aim of the study was to evaluate the clinical applicability of EORTC/MSG 2008 criteria for the diagnosis of IFI in daily practice.

Patients/methods: This multicentre, non-interventional, observational, prospective study gathered all consecutive inpatients with HMs in which an intravenous antifungal treatment was started. Exclusion criteria were a previous or concomitant transplant procedure, outpatient status and oral antifungal therapy. EORTC/MSG 2008 criteria were used to classify patients at the beginning of antifungal therapy and at 30 days. An independent board reviewed the classification of IFI given by local clinicians at T0 and T30.

Results: The highest percentage of agreement was found for possible IFI (96%), while a lower agreement was reported for proven IFI (74%), and the highest variability was observed for probable IFI (56%). At T30, the board re-evaluation confirmed a strict agreement for possible IFI only (98%). Among 306 patients classified as possible, 156 (51%) patients showed non-typical radiological findings and 45 (15%) patients presented host factors only.

Conclusions: In real life, the EORTC/MSG criteria can be applicable only for possible IFI. As non-typical radiological findings are reported in possible IFI, introducing a new IFI category should be considered.

背景:侵袭性真菌感染(IFI)是导致血液肿瘤(HMs)患者发病和死亡的一个重要原因。自 2002 年以来,基于宿主因素、临床和放射学特征以及真菌学检测的 IFI 分类法已发布,用于研究目的:这些标准被广泛应用于临床实践,以确定有 IFI 风险的患者。本研究旨在评估 EORTC/MSG 2008 标准在日常工作中诊断 IFI 的临床适用性:这项多中心、非干预性、观察性、前瞻性研究收集了所有开始接受静脉抗真菌治疗的连续 HMs 住院患者。排除标准为曾接受或同时接受移植手术、门诊病人身份和口服抗真菌治疗。EORTC/MSG 2008 标准用于对开始接受抗真菌治疗和接受治疗 30 天后的患者进行分类。一个独立委员会对当地临床医生在T0和T30时给出的IFI分类进行了审查:结果发现,对可能的 IFI 的一致率最高(96%),对已证实的 IFI 的一致率较低(74%),对可能的 IFI 的变异率最高(56%)。在 T30 阶段,委员会的重新评估证实,只有可能的 IFI 才具有严格的一致性(98%)。在306名被归类为可能的患者中,156名(51%)患者出现了非典型放射学检查结果,45名(15%)患者仅表现为宿主因素:结论:在现实生活中,EORTC/MSG 标准仅适用于可能的 IFI。结论:在现实生活中,EORTC/MSG 标准仅适用于可能的 IFI。由于在可能的 IFI 中报告了非典型的放射学结果,因此应考虑引入一个新的 IFI 类别。
{"title":"Revision of antifungal strategies definitions for invasive fungal infections (proven/probable/possible) in 461 patients with haematological malignancies (REDEFI-SEIFEM).","authors":"Criscuolo Marianna, Bonanni Matteo, Piciocchi Alfonso, Farina Francesca, Verga Luisa, Marchesi Francesco, Basilico Claudia, Del Principe Maria Ilaria, Tisi Maria Chiara, Cattaneo Chiara, Picardi Marco, Bonuomo Valentina, Fracchiolla Nicola, Candoni Anna, Perruccio Katia, Stanzani Marta, Larici Anna Rita, Sanguinetti Maurizio, Busca Alessandro, Pagano Livio","doi":"10.1111/myc.13781","DOIUrl":"https://doi.org/10.1111/myc.13781","url":null,"abstract":"<p><strong>Background: </strong>Invasive fungal infections (IFI) are a relevant cause of morbidity and mortality among patients with haematological neoplasms (HMs). Since 2002, a classification of IFI based on host factors, clinical and radiological features and mycological tests was published for research purpose.</p><p><strong>Objectives: </strong>These criteria are widely used in clinical practice to identify patients at risk for IFI. The aim of the study was to evaluate the clinical applicability of EORTC/MSG 2008 criteria for the diagnosis of IFI in daily practice.</p><p><strong>Patients/methods: </strong>This multicentre, non-interventional, observational, prospective study gathered all consecutive inpatients with HMs in which an intravenous antifungal treatment was started. Exclusion criteria were a previous or concomitant transplant procedure, outpatient status and oral antifungal therapy. EORTC/MSG 2008 criteria were used to classify patients at the beginning of antifungal therapy and at 30 days. An independent board reviewed the classification of IFI given by local clinicians at T0 and T30.</p><p><strong>Results: </strong>The highest percentage of agreement was found for possible IFI (96%), while a lower agreement was reported for proven IFI (74%), and the highest variability was observed for probable IFI (56%). At T30, the board re-evaluation confirmed a strict agreement for possible IFI only (98%). Among 306 patients classified as possible, 156 (51%) patients showed non-typical radiological findings and 45 (15%) patients presented host factors only.</p><p><strong>Conclusions: </strong>In real life, the EORTC/MSG criteria can be applicable only for possible IFI. As non-typical radiological findings are reported in possible IFI, introducing a new IFI category should be considered.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 8","pages":"e13781"},"PeriodicalIF":4.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mycoses
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1